Safety and efficacy of eculizumab in the prevention of antibody‐mediated rejection in living‐donor kidney transplant recipients requiring desensitization therapy: A randomized trial

Author:

Marks William H.12,Mamode Nizam3,Montgomery Robert A.4,Stegall Mark D.5,Ratner Lloyd E.6,Cornell Lynn D.7,Rowshani Ajda T.8,Colvin Robert B.9,Dain Bradley110,Boice Judith A.1,Glotz Denis1112,Kanellis John,Russ Graeme,Kamar Nassim,Lebranchu Yvon,Legendre Christophe,Rostaing Lionel,Hugo Christian,Colussi Giacomo,Rigotti Paolo,Reisaeter Anna,Oppenheimer Frederic,Mjörnstedt Lars,Tufveson Gunnar,Higgins Robert,Mason Philip,Torpey Nicholas,Chandraker Anil,Cooper Matthew,El‐Amm Jose,Osama Gaber A.,Mannon Roslyn,Marsh Christopher,Patel Anup,Vincenti Flavio,West‐Thielke Patricia,Wolf Joshua,Woodle Steve,

Affiliation:

1. Formerly Alexion Pharmaceuticals Boston Massachusetts

2. Independent Consultant Bellevue Washington

3. Department of Transplant Surgery Guy's and St Thomas’ Evelina London Children's and Great Ormond Street Hospitals NHS Trust London UK

4. NYU Langone Transplant Institute New York University Langone Medical Center New York New York

5. The William J. von Liebig Center for Transplantation and Clinical Regeneration and Division of Transplantation Surgery Department of Surgery Mayo Clinic Rochester Minnesota

6. Department of Surgery Columbia University New York New York

7. Department of Laboratory Medicine and Pathology Mayo Clinic Rochester Minnesota

8. Department of Internal Medicine Section of Nephrology and Transplantation Erasmus MCUniversity Medical Center Rotterdam Rotterdam The Netherlands

9. Department of Pathology Harvard Medical School Massachusetts General Hospital Boston Massachusetts

10. Independent statistics consultantGuilford Connecticut

11. Paris Translational Research Center for Organ Transplantation Institut National de la Santé et de la Recherche MédicaleUnité Mixte de Recherche‐S970 Paris France

12. Department of Nephrology and Organ Transplantation Saint‐Louis HospitalAssistance Publique‐Hôpitaux de ParisInstitut National de la Santé et de la Recherche MédicaleUnité U1160 Paris France

Funder

Alexion Pharmaceuticals

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3